Advertisement

Topics

Galapagos Company Profile

16:47 EST 18th November 2017 | BioPortfolio

We are a genomics based drug discovery company, that has drug discovery programs based on proprietary disease modifying drug targets. Our vision is to bring novel drugs to the market in selected diseases areas for which there is a need for effective and safe medicines.
We focus on developing drugs that stop or reverse a disease state using novel targets that we identify through a patent protected genomics platform. To maximise the potential of the proprietary technology, we provide access to our target and drug discovery platform through our services division BioFocus DPI.Galapagos focuses its internal programs on developing new drugs in the bone and joint diseases- osteoarthritis, osteoporosis and rheumatoid arthritis. BioFocus DPI offers a full suite of target-to-drug discovery products and services to pharmaceutical and biotech companies, encompassing target discovery to validation and drug discovery services through to delivery of pre-clinical candidates. In addition, BioFocus DPI provides adenoviral reagents for rapid identification and validation of novel drug targets, natural and synthetic compound libraries for screening, and compound management facilities for compound delivery to multiple screening centers.

Location

BioFocus DPI9640 Towne Centre Drive
San Diego
California
92121
United States of America

Contact

Phone: 1 858 455 8600
Fax: 1 858 546 3081
Email: bd@glpg.com


News Articles [66 Associated News Articles listed on BioPortfolio]

Galapagos: 3 Pillars to Success, The Galapagos Model

In this episode of PharmaTelevision News Review,filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Onno Van De Stolpe, CEO of Galapagos

Galapagos: Technology Platforms and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Onno Van de Stolpe, CEO at Galapagos. Filmed at BioBusiness 2010 in London, England, they discuss: • How Galapagos has handl...

Galapagos NV: Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study

Galapagos presents data from DARWIN 3, other filgotinib studies and Galapagos' GLPG1972 at American College of Rheumatology Meeting 2017 Mechelen, Belgium; 5 November 2017; 3 PM CET - Galapagos NV...

Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year

With the addition of uveitis, Galapagos and Gilead are raising to 10 the number of indications in filgotinib’s clinical pipeline. Galapagos and Gilead clearly have big expectations for filgotini...

Galapagos: Onno van de Stolpe, CEO

Onno van de Stolpe talks to Fintan Walton, about Galapagos' current business model and overall strategic outlook. They discuss the integration of BioFocus following its acquisition by Galapagos in Nov...

Galapagos posts impressive top-line data in lung disease

Galapagos is currently working on an agent called GLPG1690, an inhibitor of autotaxin for use in patients…

Meet the Founder & CEO of Galapagos, Europe’s Biotech Role Model

Onno van de Stolpe founded Galapagos nearly 20 years ago and still is CEO of this European biotech success story. I caught up with him for the full story.  It was when he was studying at the agricult...

#news #biotech Galapagos to take IPF drug into late-stage trial after phase 2 win

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Galapagos to take IPF drug into late-stage trial after phase 2 win .Belgian b...

Drugs and Medications [0 Results]

None

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate change.

Native biodiversity on the Galapagos Archipelago is severely threatened by invasive alien species. On Santa Cruz Island, the abundance of introduced plant species is low in the arid lowlands of the Ga...

Residency and movement patterns of an apex predatory shark (Galeocerdo cuvier) at the Galapagos Marine Reserve.

The potential effectiveness of marine protected areas (MPAs) as a conservation tool for large sharks has been questioned due to the limited spatial extent of most MPAs in contrast to the complex life ...

Benefits of the destinations, not costs of the journeys, shape partial migration patterns.

1.The reasons that lead some animals to seasonally migrate, and others to remain in the same area year-round, are poorly understood. Associations between traits, such as body size, and migration provi...

Alien species pathways to the Galapagos Islands, Ecuador.

Alien species, one of the biggest threats to natural ecosystems worldwide, are of particular concern for oceanic archipelagos such as Galápagos. To enable more effective management of alien species, ...

Intraspecific variation in feeding strategies of Galapagos sea lions: A case of trophic specialization.

The trophic behavior of marine predators varies according to the level of competition to which they are exposed. In general, populations that inhabit lower productivity systems face a strong intraspec...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Galapagos nv

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs...

Discovery Partners International

Discovery Partners recently completed the sale of all of the stock of Discovery Partners’ operating subsidiaries and all of Discovery Partners’ material operating assets pursuant to a stock and as...

Galapagos

We are a genomics based drug discovery company, that has drug discovery programs based on proprietary disease modifying drug targets. Our vision is to bring novel drugs to the market in selected disea...

More Information about "Galapagos" on BioPortfolio

We have published hundreds of Galapagos news stories on BioPortfolio along with dozens of Galapagos Clinical Trials and PubMed Articles about Galapagos for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Galapagos Companies in our database. You can also find out about relevant Galapagos Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record